## Chronic Rhinosinusitis with Nasal Polyposis: Diagnosis and Management ### Clinical Presentation and Pathophysiology **Key Point:** Chronic rhinosinusitis with nasal polyposis (CRSwNP) is characterized by inflammation lasting >12 weeks with polyp formation visible on endoscopy or imaging. **High-Yield:** Two distinct endotypes exist: 1. **Eosinophilic CRSwNP** — elevated eosinophils, often associated with asthma and NSAID sensitivity (Samter triad) 2. **Non-eosinophilic CRSwNP** — neutrophil-predominant, less allergic association ### Diagnostic Features in This Case | Finding | Significance | |---------|-------------| | Pale, boggy mucosa | Edema from chronic inflammation | | Nasal polyps | Benign, inflammatory outgrowths | | Eosinophil-rich secretion | Suggests eosinophilic phenotype | | Bone remodeling on imaging | Indicates long-standing inflammation | | Symptoms >12 weeks | Meets chronicity criterion | ### Medical Management — First-Line Therapy **Key Point:** Topical intranasal corticosteroids (INCS) are the gold standard first-line treatment. **High-Yield:** INCS efficacy in CRSwNP: - Reduce polyp size and nasal obstruction - Decrease eosinophilic inflammation - Improve quality of life scores - Prevent polyp recurrence post-surgery - Examples: mometasone, fluticasone propionate, beclomethasone ### Aspirin Desensitization — Limited Indication **Warning:** Aspirin desensitization is NOT a proven treatment for all patients with CRSwNP. It is indicated ONLY in a specific subset: 1. **Samter Triad** (aspirin-exacerbated respiratory disease, AERD): - Chronic rhinosinusitis + nasal polyps - Asthma - Reactions to NSAIDs/aspirin 2. **Mechanism:** Desensitization shifts eicosanoid metabolism away from leukotriene production. 3. **Evidence:** Proven benefit in AERD patients, NOT in all CRSwNP. **Clinical Pearl:** Aspirin desensitization requires: - Careful patient selection (confirmed AERD) - Supervised protocol in specialized centers - Long-term aspirin maintenance therapy - Risk of anaphylaxis during desensitization ### Surgical Management **Key Point:** Endoscopic sinus surgery (ESS) is indicated when: - Medical therapy (INCS, saline irrigation, antibiotics) fails after 3–6 months - Symptoms significantly impair quality of life - Complications develop (orbital/intracranial extension) **High-Yield:** ESS goals: - Restore ostiomeatal complex patency - Improve mucociliary drainage - Reduce bacterial biofilm burden - Allow better penetration of topical medications post-operatively ### Why Option 3 (Aspirin Desensitization for All) Is Wrong **High-Yield:** Aspirin desensitization is a specialized intervention for AERD (Samter triad), not a general treatment for all CRSwNP patients. Most CRSwNP patients do not have AERD and do not benefit from aspirin desensitization. Routine use is not evidence-based and carries unnecessary risk. [cite:Harrison 21e Ch 146; Park 26e Ch 31]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.